OPPORTUNITY AFRICAN MARKET FOR INDIAN COMPANIES G.K. Raman Regional Director PHARMEXCIL
INDIAN PHARMACEUTICAL INDSTRY Manufacturers over 400 APIs (BULK DRUGS) Manufacturers over 10,000 medicaments (Formulations) Almost Self Sufficient (95%) in domestic requirement Total Pharmaceutical export 6.8 bn dollars (approximate) Ranks 4 th Globally in volume terms Ranks 13 th globally in value terms Among top 5 global producers of bulk drugs
Key Strengths Well developed industry with strong manufacturing base Cost competitiveness Well established network of laboratories and R&D infrastructure Highly trained pool of scientists and professionals World class quality products Strong marketing and distribution network Very strong process development skills Potential ground for clinical trials Fast growing biotechnology industry
CURRENT GLOBAL STATUS Emerging as tough compititor to Europe as a growing Pharmqa R&D Hub An emerging hub for collaborative R&D in drug development, biotechnology and process developments Shift from business driven research to research driven business Topped in drug fillings with US FDA (more than 150 DMFs) A preferred destination for several multinationals (Roche, Aventis, Chiron) for sourcing of APIs Fast growing clinical research activity with increased activity of MNCs like Pfizer, Novartis, Astra Zenica, Eli Lilly etc.) Largest number of US FDA approved plants outside US.
Pharmaceutical Industry Profile Market Size Growth 12.78% Number of Units(Large) 300 Multinational Companies 25 APIs Used 550 APIs manufactured 400 Medicines (Packs) Marketed US$ 5.66 billion 20,000 (Trade Channers)
Trade with Africa Countries US$ % Growth Total Pharma Export 5.66 12.78 African Coutries 0.87 17.81 Share of Exports to African Countries 13.53%
India s Export to Africa Region Wise for 2005-2006 US$ mlln % Share % Growth Western Africa 213.24 34.49 16.75 Southern Africa 158.27 25.60 76.62 East Africa 137.85 22.30 49.03 North Africa 66.54 10.76 17.04 Central Africa 42.39 6.86 13.62
TOP 5 countries Sorted by Share of Market Region Wise Southern Africa North Africa South Africa 62.08% Sudan 34.23% Zambia 12.02% Egypt 30.41% Angola 10.12% Algeria 23.69% Mozambique 4.80% Morocco 6.58% Namibia 3.72% Libya 3.33% East Africa West Africa Kenya 36.71% Nigeria 53.37% Tanzania 19.54% Ghana 16.36% Uganda 18.58% Guinea 8.50% Ethopia 14.26% Benin 4.01% Mauritius 6.18% Senegal 3.01% Central Africa Chad 4.18% Gabon 3.75% Cameroon 33.31% Congo Rep 0.68% Equtl Guinea 0.28
Fast Growing African Market Growth Rate % Mozambique 174.59 Libya 198.30 South Africa 104.13 Senegal 120.58
African Market Major Therapeutic Segments Anti Malaria Anti Tubercular Anti HIV Anti Microbial Haematanics Gastro-Intestinals Cardio-Vascular Anti Diabetes Cough cold syrup Deramatology Anti Fungals
What India can offer to African countries Joint Ventures with African / European countries who have already established presence Technology Transfer of Biotech Products / Vaccines Enter into Alliance with African Companies Acquisition / Merger with established African companies Establish API / Formulations manufacture in Anti Biotic / HIV Segments Establish a good network for supply chain management Supply quality medicines at competitive prices for : HIV / AIDS drugs Anti Biotics TB medicines Medicine for Cardiac Disease Medicines for Anemia Child healthcare medicines Supplies against global tenders Supply generic medicines
AREAS TO BE FOCUSSED Fast Track registration for Indian Dosage Forms Single inspector agencies for plant inspection Creation of Forum for sorting out quality issues Mutual cooperation on regulatory issues for solving problem of sub standard drugs Accreditation of reputed Indian testing labs for facilitating pharma exports.
THANK YOU www.pharmexcil.com rodelhi@pharmexcil.com